Skip to content

KARAR MEDICAL

Active Private limited companyfounded 2003active for 22 yearsFranklin Rooseveltlaan 135, 1050 BrusselsKBO/BCE: BE 0862.455.407

Lifetime

19 annual accounts with figures on one time axis, 21 filings since 2005
peak of €356,090 in 2016
€206,785▼ 27.3%
lowest -€87,611 in 2010
-€35,484▼ €80,792
peak of €141,070 in 2024
€105,586▼ 25.2%
€2.0m▲ 22.4%
peak of 1.5 FTE in 2012
-not published
Board2 names since 2014
1 director
Documentsfilings and deeds
24-12-202538 days before the deadline
2025micro format
Gross margin from €284,567 to €206,785Loss of €35,484Equity from €141,070 to €105,586Debts from €1.7m to €2.0mInvestments €521,783Cash from €24,688 to €2,675

Key points

from the 2025 annual accounts

Overdue debts

€33,624 on 30-06-2025

The annual accounts state €33,624 of overdue tax debts on 30-06-2025.

Result

-€35,484 -€35,484
€45,3002024-€35,5002025

From profit to loss in 2025, after a profit of €45,307 in 2024.

Debts

€2.0m 95% of the balance sheet
Financial debts 67%Suppliers 4%Taxes and wages 5%Other 24%

Of this, €776,626 falls due within a year.

Investments

€521,783 3.4 times depreciation
20202022202320242025

Green is investment, beige is depreciation. Machinery stands 1128.0% higher than in 2024.

Filings

21 annual accounts since 2005
deadline20052010201520202025

The 2017 accounts came 1 day late. The other nine of the last ten were filed on time.

Position in the sector

-€35,484

Lower net result than 95% of companies in human health. Sector median €59,553 · 21,334 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,104 companies had the same profile as KARAR MEDICAL has now. Each dot stands for 3 companies, two years later.

94.3%
were still trading
3.5%
stopped another way
1.8%
went bankrupt
  • Small
  • 20 years or older
  • solvency under 10%
  • a small loss

Another 0.4% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,104 companies, not a prediction for KARAR MEDICAL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 01-07-2016
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0862455407
changes role from manager to director Director discharge: · Gazette deed
New manager appointed, resigned · General meeting of 04-10-2016 · Gazette deed
reappointed as manager General meeting of 26-12-2014 · Gazette deed
All 35 events

Comparable companies

same main activity, similar in size and age
Company
KARAR MEDICAL Brussels €2.2m €206,785 4.9% -
SOCIETE MEDICALE DU DOCTEUR CUVELIER PIERRE Gerpinnes €2.2m €198,360 83.3% -
DR.MAES - DR.RYCKAERT Sint-Niklaas €2.1m €213,118 40.7% -
DENEUCARE Ottignies-Louvain-la-Neuve €2.1m €186,593 59.9% -
Dr KEMNITZ SPRL Voeren €2.0m €232,082 60.6% -
DR. INGRID DE GREEF, GYNAECOLOGIE Beersel €2.1m €209,625 92.9% -
DR. ROBERT VANDEURZEN Oud-Turnhout €2.1m €236,404 93.6% -

These companies have the same main activity as KARAR MEDICAL: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €2m and €2.2m, founded between 2002 and 2007.

Official details

Source: KBO
Status
Active since 31-12-2003Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Establishment unit
2.228.827.0021050 Brussels, since 31-12-2003
Financial year end
30 June
Peppol
Reachable since 16-10-2025
Company details

Annual accounts to 30-06-2025

≈ €380,000estimated
€2.2m▲ 18.7%
≈ 0.9 FTEestimated
Filing
Filed on 24-12-2025, 38 days before the end of the filing period
Financials

Insights on KARAR MEDICAL

KARAR MEDICAL files the micro format. That format states no turnover. The gross margin rose from €81,644 in 2007 to €206,785 in 2025.

The balance sheet grew most from 2009 to 2010 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about KARAR MEDICAL

What is the company number of KARAR MEDICAL?
The company number of KARAR MEDICAL is 0862.455.407. The VAT number is the same number with BE in front: BE 0862.455.407.
Where is KARAR MEDICAL based?
The registered office is at Franklin Rooseveltlaan 135, 1050 Brussels.Company details
What does KARAR MEDICAL do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of KARAR MEDICAL?
KARAR MEDICAL is a private limited company (BV).
When was KARAR MEDICAL founded?
KARAR MEDICAL was founded on 31-12-2003.
Is KARAR MEDICAL still active?
Yes, KARAR MEDICAL is an active enterprise in the KBO register.
How many employees does KARAR MEDICAL have?
KARAR MEDICAL had an average of 1 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
What is the turnover of KARAR MEDICAL?
The turnover in financial year 2025 is ≈ €380,000. This figure is estimated from the gross margin of €206,785 and 40 comparable companies (NACE 86220). It probably lies between €330,000 and €510,000.
Is KARAR MEDICAL profitable?
In financial year 2025, KARAR MEDICAL made a loss of €35,484.
Where can I find the annual accounts of KARAR MEDICAL?
KARAR MEDICAL filed 21 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of KARAR MEDICAL due?
KARAR MEDICAL must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.